Jörg Trojan

10.5k total citations
107 papers, 3.1k citations indexed

About

Jörg Trojan is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jörg Trojan has authored 107 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 25 papers in Hepatology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jörg Trojan's work include Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Colorectal Cancer Treatments and Studies (16 papers) and Virtual Reality Applications and Impacts (16 papers). Jörg Trojan is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Colorectal Cancer Treatments and Studies (16 papers) and Virtual Reality Applications and Impacts (16 papers). Jörg Trojan collaborates with scholars based in Germany, United States and Switzerland. Jörg Trojan's co-authors include Martin Riemer, Xaver Fuchs, Martin Diers, Dieter Kleinböhl, Rupert Hölzl, Herta Flor, Stefan Zeuzem, Martin Fuchs, Helmut Oettle and Jens Foell and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Jörg Trojan

104 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jörg Trojan Germany	29	898	834	814	487	441	107	3.1k
Sandra Costa Portugal	27	668 0.7×	58 0.1×	179 0.2×	247 0.5×	337 0.8×	77	2.3k
Sara Conti Italy	35	179 0.2×	31 0.0×	256 0.3×	54 0.1×	300 0.7×	56	3.8k
David Berry United States	26	176 0.2×	118 0.1×	105 0.1×	91 0.2×	385 0.9×	127	2.2k
Michael C. Jin United States	15	124 0.1×	47 0.1×	178 0.2×	44 0.1×	157 0.4×	75	1.3k
Giulia Di Stefano Italy	34	194 0.2×	51 0.1×	337 0.4×	215 0.4×	179 0.4×	128	3.7k
Tomohiro Ishii Japan	29	133 0.1×	402 0.5×	228 0.3×	26 0.1×	325 0.7×	177	2.6k
Yevgeniy R. Semenov United States	26	457 0.5×	38 0.0×	228 0.3×	266 0.5×	180 0.4×	122	2.0k
Giuseppe Calcagno Italy	26	111 0.1×	27 0.0×	161 0.2×	110 0.2×	180 0.4×	87	1.7k
Eleonora Cocco Italy	32	473 0.5×	15 0.0×	527 0.6×	62 0.1×	66 0.1×	238	4.1k
Mark A. Hoffman United States	26	213 0.2×	32 0.0×	113 0.1×	193 0.4×	88 0.2×	76	2.4k

Countries citing papers authored by Jörg Trojan

Since Specialization

Citations

This map shows the geographic impact of Jörg Trojan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Trojan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Trojan more than expected).

Fields of papers citing papers by Jörg Trojan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Trojan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Trojan. The network helps show where Jörg Trojan may publish in the future.

Co-authorship network of co-authors of Jörg Trojan

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Trojan. A scholar is included among the top collaborators of Jörg Trojan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Trojan. Jörg Trojan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schulze, Falko, et al.. (2024). Diagnostic performance of non-invasive liver fibrosis scores in patients with early-intermediate hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 150(4). 187–187. 1 indexed citations

Goetze, Thorsten Oliver, Alexander Reichart, Claudia Pauligk, et al.. (2024). Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial. Annals of Surgical Oncology. 31(6). 4073–4083. 2 indexed citations

Vogl, Thomas J., et al.. (2024). The combination of transarterial chemoembolization and microwave ablation is superior to microwave ablation alone for liver metastases from colorectal cancer. Journal of Cancer Research and Clinical Oncology. 150(10). 440–440. 1 indexed citations

Sinn, Marianne, Klara Dorman, Gabriele Margareta Siegler, et al.. (2024). 1525P Nab-paclitaxel/gemcitabine with or without epigenetic targeting followed by consolidating immune targeting with durvalumab and lenalidomide in patients with advanced pancreatic ductal adenocarcinoma: Results from the SEPION/AIO-PAK-0118 phase I/II study. Annals of Oncology. 35. S931–S931. 2 indexed citations

Heil, Jan, C Herfarth, Wolf O. Bechstein, et al.. (2023). Chemotherapy and Targeted Therapy Strategies in Patients with Unresectable or Borderline Resectable Metastatic Colorectal Cancer: Evidence for a Lack of Focus on Resection Rates. Annals of Surgical Oncology. 30(12). 7624–7632. 1 indexed citations

Trojan, Jörg, et al.. (2023). ADAPTATION OF QGIS TOOLS IN HIGH SCHOOL GEOGRAPHY EDUCATION. SHILAP Revista de lepidopterología. XLVIII-4/W7-2023. 161–168. 1 indexed citations

Trojan, Jörg, et al.. (2022). Liver resection after Transjugular Portosystemic Stent Shunt (TIPSS). Zeitschrift für Gastroenterologie. 61(4). 390–393. 1 indexed citations

Diers, Martin, Bertram Krumm, Xaver Fuchs, et al.. (2021). The Prevalence and Characteristics of Phantom Limb Pain and Non-Painful Phantom Phenomena in a Nationwide Survey of 3,374 Unilateral Limb Amputees. Journal of Pain. 23(3). 411–423. 17 indexed citations

Kafatos, George, Victoria Banks, David Neasham, et al.. (2021). Impact of Biomarkers and Primary Tumor Location on the Metastatic Colorectal Cancer First-Line Treatment Landscape in Five European Countries. Future Oncology. 17(12). 1495–1505. 2 indexed citations

10.

Moehler, Markus, Alexander Stein, Jörg Trojan, et al.. (2020). PD-8 Regorafenib with TAS-102 in metastatic colorectal cancer patients who progressed after at least two standard therapies: Efficacy and safety results of a multicenter phase I study (REMETY). Annals of Oncology. 31. S214–S214. 1 indexed citations

11.

Koch, Christine, Ria Winkelmann, Katrin Eichler, et al.. (2018). Anti-EGF Receptor-Based Conversion Chemotherapy in RAS Wild-Type Colorectal Cancer Patients: Impact on Survival and Resection Rates. Digestion. 98(4). 263–269. 2 indexed citations

12.

Al‐Batran, Salah‐Eddin, Claudia Pauligk, Nils Homann, et al.. (2017). Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) as perioperative treatment of resectable gastric or gastro-esophageal junction adenocarcinoma: The multicenter, randomized phase 3 FLOT4 trial (German Gastric Group at AIO). Annals of Oncology. 28. iii152–iii153. 18 indexed citations

13.

Trojan, Jörg, Susanne Klein‐Scory, Christine Koch, Wolff Schmiegel, & Alexander Baraniskin. (2017). Clinical Application of Liquid Biopsy in Targeted Therapy of Metastatic Colorectal Cancer. Case Reports in Oncological Medicine. 2017(1). 6139634–6139634. 11 indexed citations

14.

Hawighorst, Maren, et al.. (2016). Comfort-related feedforward information: occupants’ choice of cooling strategy and perceived comfort. Building Research & Information. 45(1-2). 222–238. 21 indexed citations

15.

Rance, Mariela, Jörg Trojan, Xaver Fuchs, et al.. (2015). Do Mirror Glasses Have the Same Effect on Brain Activity as a Mirror Box? Evidence from a Functional Magnetic Resonance Imaging Study with Healthy Subjects. PLoS ONE. 10(5). e0127694–e0127694. 13 indexed citations

16.

Hinrichsen, Inga, Angela Brieger, Jörg Trojan, et al.. (2013). Expression Defect Size among Unclassified MLH1 Variants Determines Pathogenicity in Lynch Syndrome Diagnosis. Clinical Cancer Research. 19(9). 2432–2441. 26 indexed citations

17.

Trojan, Jörg, Christian Maihöfner, Rupert Hölzl, et al.. (2013). Spatiotemporal integration of tactile patterns along and across fingers. Neuropsychologia. 53. 12–24. 3 indexed citations

18.

Vogl, Thomas J., Nour-Eldin A. Nour-Eldin, S Zangos, et al.. (2010). Regionale interventionelle Behandlungsverfahren von Lebermetastasen neuroendokriner Tumoren: Embolisation (TAE), Chemoembolisation (TACE) und selektive interne Radiotherapie (SIRT). 26(4). 269–275. 1 indexed citations

19.

Buster, Erik H.C.J., Hajo J. Flink, Yılmaz Çakaloğlu, et al.. (2008). Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b. Gastroenterology. 135(2). 459–467. 300 indexed citations

20.

Trojan, Jörg, et al.. (2004). In vitro chemosensitivity to gemcitabine, oxaliplatin and zoledronic acid predicts treatment response in metastatic gastric cancer. Anti-Cancer Drugs. 16(1). 87–91. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact